Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31.9Revenue (TTM) $M13.6Net Margin (%)-297.5Altman Z-Score-5.5
Enterprise Value $M27.4EPS (TTM) $-9.1Operating Margin %-77.3Piotroski F-Score5
P/E(ttm)--Beneish M-Score-4.1Pre-tax Margin (%)-297.5Higher ROA y-yN
Price/Book0.910-y EBITDA Growth Rate %-8.8Quick Ratio1.5Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %14.1Current Ratio2.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-81.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-118.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M9.9ROIC % (ttm)-35.5Gross Margin Increase y-yY

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

KOOL is held by these investors:



KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boyalife (Hong Kong) Ltd10% Owner 2016-12-26Buy6,102,942$2.5223.02view
Harris KennethFormer Director/Officer 2015-11-10Sell4,043$12-74.17view
Harris KennethFormer Director/Officer 2015-11-03Sell526$12-74.17view
Harris KennethFormer Director/Officer 2015-10-29Sell432$12-74.17view
Plavan Matthew TFormer CEO 2015-09-02Sell864$13.6-77.21view
Rhein Denis MichaelDirector 2014-12-01Sell0$0-77.21view
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy1,125$46-93.26view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy5$48.8-93.65view
ENGLE J MELVILLECEO 2009-09-25Buy1,250$45.6-93.2view
MCENANY PATRICK JDirector 2009-05-19Buy313$46.4-93.32view

Press Releases about KOOL :

Quarterly/Annual Reports about KOOL:

News about KOOL:

Articles On GuruFocus.com
CESCA Therapeutics to Present at the 2017 International Symposium of Translational Medicine in Stem Apr 11 2017 
Cesca Therapeutics’ Management Delivers Keynote Speech at the 2017 Shenzhen International Preci Apr 07 2017 
Cesca Therapeutics Announces Senior Management Promotions Apr 03 2017 
Cesca CLI Feasibility Study Published in Peer-Reviewed Journal Mar 20 2017 
Cesca Therapeutics Highlights Promising Data for the Treatment of Chronic Non-Healing Ulcers Mar 15 2017 
Cesca Therapeutics Announces Closing of $5 Million Revolving Line of Credit Mar 13 2017 
Insiders Roundup: Vera Bradley Tops List Dec 30 2016 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 

More From Other Websites
CESCA Therapeutics to Present at the 2017 International Symposium of Translational Medicine in Stem... Apr 11 2017
Cesca Therapeutics’ Management Delivers Keynote Speech at the 2017 Shenzhen International... Apr 07 2017
Cesca Therapeutics Announces Senior Management Promotions Apr 03 2017
Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017 Mar 20 2017
Cesca CLI Feasibility Study Published in Peer-Reviewed Journal Mar 20 2017
Blog Coverage Cesca Therapeutics Announces Encouraging Results from a Study of its Treatment of... Mar 16 2017
Wednesday’s Biggest Biopharma Movers Mar 15 2017
Cesca Therapeutics' stock soars on heavy volume after 'encouraging' study results Mar 15 2017
Cesca Therapeutics Highlights Promising Data for the Treatment of Chronic Non-Healing Ulcers Mar 15 2017
Cesca Therapeutics Announces Closing of $5 Million Revolving Line of Credit Mar 13 2017
Cesca Therapeutics Strengthens Leadership Team and Board of Directors Feb 28 2017
Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update Feb 13 2017
Cesca Therapeutics to Announce Second Quarter Fiscal 2017 Results on February 13, 2017 Feb 09 2017
Insiders Keep Buying as Market Wraps on 2016: Tronic, Six Flags, Virtu Financial, Cesca Therapeutics... Jan 01 2017
Nvidia (NVDA) Can’t Shake Citron, Cempra (CEMP) Slammed by FDA Rejection, Plus 3 Other Major... Dec 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)